AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Introduction
An update on the drug discovery sector, highlighting the efficacy and benefits of a new bi-specific treatment for relapsed or refractory diffuse large B-cell lymphoma. Professor Chris Fox emphasizes the significance of this novel treatment for patients with limited options.